OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitisECCO '18 Vienna
2018
OP005: Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction studyECCO '18 Vienna
2018
OP006: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patientsECCO '18 Vienna
2018
OP007: α4β7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophagesECCO '18 Vienna
2018
OP008: Detection of mucosal healing with a serum marker panel in adalimumab-treated patients with ulcerative colitisECCO '18 Vienna
2018
OP009: A combination of clinical, serological, and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based studyECCO '18 Vienna
2018
OP010: Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitisECCO '18 Vienna
2018
OP011: Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effectsECCO '18 Vienna
2018
OP012: IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn’s disease patientsECCO '18 Vienna
2018
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn’s diseaseECCO '18 Vienna
2018
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndromeECCO '18 Vienna
2018
OP015: Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALMECCO '18 Vienna
2018
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014ECCO '18 Vienna
2018
OP018: High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signallingECCO '18 Vienna
2018
OP020: The clinical determinants affect gut microbial profile of inflammatory bowel disease patientsECCO '18 Vienna
2018